Rationale for the use of alpha-blockers in the treatment of benign prostatic hyperplasia (BPH)

Int J Urol. 1994 Sep;1(3):203-11. doi: 10.1111/j.1442-2042.1994.tb00036.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adrenergic alpha-Antagonists / therapeutic use*
  • Humans
  • Male
  • Prostatic Hyperplasia / drug therapy*

Substances

  • Adrenergic alpha-Antagonists